| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Gillian Beth Zucker is Director at HLI. Gillian Beth Zucker's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $958K at current prices.
Our model assigns Gillian Beth Zucker a middling insider score of 60/100, based on 12 past trades. Over a 12-month horizon, 58.3% of those trades were profitable, with an average 12-month return of +0.2%.
The HLI filings lean toward selling, a net 2,400 shares.
Gillian Beth Zucker has 20 Form 4 filings on record from November 2019 to May 2026, all as Director at Houlihan Lokey (HLI), 2019–2026.
The 20 reported transactions were 12 open-market sales and 8 stock awards.
Counted by filing, the open-market trades come to no purchases and 12 sales worth about $409K.
The largest open-market sale was 200 shares of HLI at an average $191.65 on July 14, 2025, about $38K. Twelve months later HLI was down 30%.
All 12 sales since April 2023 were made under a Rule 10b5-1 trading plan, set up in advance.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2025 | HLI Houlihan Lokey, Inc. | Director | Sell10b5-1 | 200 | $191.65 | $38,330.00 | -3.5% | -1.7% | -29.6% | |
| Jun 13, 2025 | HLI Houlihan Lokey, Inc. | Director | Sell10b5-1 | 200 | $174.37 | $34,874.00 | -3.4% | +21.4% | -19.5% | |
| May 13, 2025 | HLI Houlihan Lokey, Inc. | Director | Sell10b5-1 | 200 | $178.46 | $35,692.00 | -3.7% | +6.7% | -15.7% | |
| Apr 14, 2025 | HLI Houlihan Lokey, Inc. | Director | Sell10b5-1 | 200 | $154.41 | $30,882.00 | -3.6% | +25.5% | -2.3% | |
| Mar 13, 2025 | HLI Houlihan Lokey, Inc. | Director | Sell10b5-1 | 200 | $158.27 | $31,654.00 | -3.4% | +12.0% | -10.6% | |
| Feb 13, 2025 | HLI Houlihan Lokey, Inc. | Director | Sell10b5-1 | 200 | $178.97 | $35,794.00 | -3.3% | +0.1% | -7.1% | |
| Jan 13, 2025 | HLI Houlihan Lokey, Inc. | Director | Sell10b5-1 | 200 | $165.63 | $33,126.00 | -3.2% | -6.0% | +9.5% | |
| Dec 13, 2024 | HLI Houlihan Lokey, Inc. | Director | Sell10b5-1 | 200 | $180.57 | $36,114.00 | -3.1% | -12.1% | +1.1% | |
| Nov 13, 2024 | HLI Houlihan Lokey, Inc. | Director | Sell10b5-1 | 200 | $187.46 | $37,492.00 | -3.0% | -3.2% | -2.9% | |
| Oct 14, 2024 | HLI Houlihan Lokey, Inc. | Director | Sell10b5-1 | 200 | $168.08 | $33,616.00 | -2.9% | -2.6% | +14.3% |